Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence

@article{Cooper2006ContinuousTO,
  title={Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence},
  author={B. Cooper and W. Chapman and C. S. Neumann and J. Gearty},
  journal={Alimentary Pharmacology & Therapeutics},
  year={2006},
  volume={23}
}
There is little evidence that treatment of patients with Barrett's oesophagus with proton pump inhibitors over periods up to 6 years results in major regression of Barrett's oesophagus. 
View on Wiley
onlinelibrary.wiley.com
105 Citations
Highly Influential Citations
2
Background Citations
17
Results Citations
2

105 Citations

Citation Type

Citation Type

Proton pump inhibitor use may not prevent high‐grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients
  • 72
  • PDF
Influence of Long-Term Use of Proton Pump Inhibitors on Esophageal and Gastrointestinal Precancerous Lesions or Carcinoma
  • PDF
Advances in the therapy of Barrett's Esophagus
Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma
  • 24
One year treatment of Barrett's oesophagus with proton pump inhibitors (a multi-center study).
  • 1
One year treatment of Barrett’s oesophagus with proton pump inhibitors (a multi-center study)
  • 2
Barrett esophagus: Definition, treatment
  • S. Lai
  • Medicine
  • Cleveland Clinic Journal of Medicine
  • 2020
Treatment of Barrett ’ s esophagus
  • PDF
The effects of high‐dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett’s oesophagus
  • 21
Barrett's esophagus: endoscopic treatments I
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 82 REFERENCES
Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
  • 176
  • PDF
Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett’s oesophagus
  • 90
Long term continuous omeprazole treatment of patients with Barrett's oesophagus
  • 92
Regression of columnar‐lined (Barrett’s) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy
  • 108
Maximal acid reflux control for Barrett’s oesophagus: feasible and effective
  • 85
Review article: management of oesophageal adenocarcinoma — control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus
  • 39
The spectrum of columnar-lined esophagus--Barrett's esophagus.
  • 49
Barrett’s oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
  • 67
  • PDF
Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus
  • 39
Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study
  • 266
  • PDF
...
1
2
3
4
5
...